Condition
HIV-Associated Cognitive Motor Complex
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
50.0%
3 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Completed3
Terminated3
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03581305Phase 1Completed
PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects
NCT03122288Not ApplicableCompletedPrimary
Individualized Cognitive Training in HIV
NCT03081117Phase 1Terminated
Intranasal Insulin for the Treatment of HAND
NCT00459693Not ApplicableTerminated
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
NCT01547754TerminatedPrimary
Mild Neurocognitive Disorder in HIV Infection of the Brain
NCT03244488Completed
Mental Ability Challenge Study in Adults With and Without HIV
Showing all 6 trials